Form 4 for AXSM Axsome Therapeutics, Inc.

Accepted 2026-06-10 21:49:14 ET · period of report 2026-06-08 · accession 0001193125-26-266433 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DT	2026-06-10 21:49	2026-06-08	AXSM	Coleman Mark	Dir	M - OptEx	—	+1,429	31.0K	+5%	—
DT	2026-06-10 21:49	2026-06-10	AXSM	Coleman Mark	Dir	S - Sale+OE	$249.00	-643	30.4K	-2%	-$160.1K
DT	2026-06-10 21:49	2026-06-08	AXSM	Coleman Mark	Dir	M - OptEx	$0.00	-1,429	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-08	M	A	1,429	—	31,032	D	—	—	(F2) On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant. (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
2	Common	Common Stock	2026-06-10	S	D	643	$249.00	30,389	D	—	—	(F3) Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed. (F4) These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025. (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $245.17 and $253.04.
3	Derivative	Restricted Stock Units	2026-06-08	M	D	1,429	$0.00	0	D	— · — to —	1,429 Common Stock	(F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.